Impact of COVID-19 on the pre and post analytical clinical laboratory testing processes- A performance evaluation study using six sigma
Open Access
- 9 September 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 70, 102842
Abstract
The aim of this study was to determine the impact of COVID-19 pandemic on the total testing process using six sigma metrics based on a comparison of pre and during pandemic periods. The study duration was over 12 months, 6 months before and 6 months after the COVID-19 onset in Pakistan in March 2020 after the recognition of the first case, using quality indicators (QIs). QIs were chosen from a model of QIs recommended by the CAP. Analysis was performed using Six Sigma calculators and QIs were expressed in percentage (%) and Sigma value were computed. Three levels of performance quality i.e. 25th, 50th, and 75th percentile were derived, being best, common and worst performance respectively. Between-group differences were tested using the Mann-Whitney's U test. The median defect percentages of these QIs ranged from 0% to 0.27% for the pre-pandemic period and 0% to 0.13% for the during pandemic period. Meanwhile, sigma values of the majority of the QIs were all above 4.0σ during the pre and the pandemic times. For the pre-analytical phase, sigma scores declined for 1 QI, improved for 3 QIs and remained same for 2. In the post analytical phase, no change in sigma metrics was noted for critical values notification. Considerable increase in defect percentage of inappropriate turnaround times was noted. The emergency preparedness proved to be fruitful as depicted by exceptional performance on the sigma metrics for most Qis both prior to and during the pandemic. The pre-analytical and the post analytical phases, being the most error sensitive requires strict vigilance.Keywords
This publication has 17 references indexed in Scilit:
- Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidenceClinical Chemistry and Laboratory Medicine (CCLM), 2020
- The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaksClinical Chemistry and Laboratory Medicine (CCLM), 2020
- STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgeryInternational Journal of Surgery, 2019
- Quality Indicators for the Total Testing ProcessClinics In Laboratory Medicine, 2017
- Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” projectClinical Chemistry and Laboratory Medicine (CCLM), 2016
- Preanalytical quality improvement: from dream to realityClinical Chemistry and Laboratory Medicine (CCLM), 2011
- The detection and prevention of errors in laboratory medicineAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2009
- The IFCC Working Group on laboratory errors and patient safetyClinica Chimica Acta, 2009
- Identification errors involving clinical laboratories: a College of American Pathologists Q-Probes study of patient and specimen identification errors at 120 institutions.Archives of Pathology & Laboratory Medicine, 2006
- The College of American Pathologists, 1946-1996. Quality Assurance Service.1997